EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Sakura Yamamura, Koji Sawada und 23 weitere

Clinical Gastroenterology and Hepatology · 2023-02 · 21 (2) · 370-379

DOI: 10.1016/j.cgh.2022.01.002 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-02. Verfasst von Hideki Fujii und 34 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan; Department of Hepatology, Graduate Scho…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: There are no detailed reports of clinical outcomes in Asian patients with nonalcoholic fatty liver disease (NAFLD) who undergo liver biopsy. We aimed to investigate the clinical outcomes of a large cohort of Asian patients with biopsy-proven NAFLD and evaluate the specific effects of nonalcoholic steatohepatitis and fibrosis stage. METHODS: This multicenter registry-based retrospective cohort study, called the CLIONE (Clinical Outcome Nonalcoholic Fatty Liver Disease) in Asia, included 1398 patients. RESULTS: The median follow-up period was 4.6 years (range, 0.3-21.6 years), representing a total of 8874 person-years of follow-up. During that time, 47 patients died, and 1 patient underwent orthotopic liver transplantation. The leading cause of death was nonhepatic cancer (n = 10). The leading causes of liver-related death were liver failure (n = 9), hepatocellular carcinoma (HCC) (n = 8), and cholangiocellular carcinoma (n = 4). During follow-up, 37 patients developed HCC, 31 developed cardiovascular disease, and 68 developed nonhepatic cancer (mainly breast, stomach, and colon/rectum). Among our cohort of patients with NAFLD, liver-specific mortality was 2.34/1000 person-years (95% confidence interval [CI], 1.52-3.58), overall mortality was 5.34/1000 person-years (95% CI, 4.02-7.08), and HCC incidence was 4.17/1000 person-years (95% CI, 3.02-5.75). Liver fibrosis was independently associated with liver-related events but not overall mortality. CONCLUSIONS: Liver-related mortality was the leading cause of mortality in Asian patients with biopsy-confirmed NAFLD. Although fibrosis stage was independently associated with liver-related events, it was not associated with overall mortality after adjusting for confounders, such as histologic features of steatohepatitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCarcinoma, HepatocellularLiver NeoplasmsHumansCohort StudiesRetrospective StudiesLiverLiver CirrhosisBiopsy

Stichwörter der Autor:innen

AsianCirrhosisFibrosisLiver-related Mortality

Autor:innen und Institutionen

  • Departments of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
  • Division of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Department of Gastroenterology and Hepatology, Gifu Municipal Hospital, Gifu, Japan.
  • Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Liver Center, Saga University Hospital, Saga, Japan; Department of Laboratory Medicine, Saga University Hospital, Saga, Japan.
  • Department of Gastroenterology, JA Hiroshima Kouseiren General Hospital, Hatsukaichi, Hiroshima, Japan.

Zitieren

APA

Fujii, H., Iwaki, M., Hayashi, H., Toyoda, H., Oeda, S., Hyogo, H., Kawanaka, M., Morishita, A., Munekage, K., Kawata, K., Yamamura, S., Sawada, K., Maeshiro, T., Tobita, H., Yoshida, Y., Naito, M., Araki, A., Arakaki, S., Kawaguchi, T., …, & Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD) (2023). Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study. Clinical Gastroenterology and Hepatology, 21(2), 370-379. https://doi.org/10.1016/j.cgh.2022.01.002

Vancouver

Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, et al. Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study. Clinical Gastroenterology and Hepatology. 2023;21(2):370-379. doi:10.1016/j.cgh.2022.01.002

BibTeX
@article{Fujii2023,
  author = {Fujii, Hideki and Iwaki, Michihiro and Hayashi, Hideki and Toyoda, Hidenori and Oeda, Satoshi and Hyogo, Hideyuki and Kawanaka, Miwa and Morishita, Asahiro and Munekage, Kensuke and Kawata, Kazuhito and Yamamura, Sakura and Sawada, Koji and Maeshiro, Tatsuji and Tobita, Hiroshi and Yoshida, Yuichi and Naito, Masafumi and Araki, Asuka and Arakaki, Shingo and Kawaguchi, Takumi and Noritake, Hidenao and Ono, Masafumi and Masaki, Tsutomu and Yasuda, Satoshi and Tomita, Eiichi and Yoneda, Masato and Kawada, Norifumi and Tokushige, Akihiro and Kamada, Yoshihiro and Takahashi, Hirokazu and Ueda, Shinichiro and Aishima, Shinichi and Sumida, Yoshio and Nakajima, Atsushi and Okanoue, Takeshi and Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)},
  title = {Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {2},
  pages = {370--379},
  doi = {10.1016/j.cgh.2022.01.002}
}
Kostenlos starten →